We have observed
3 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after May 22, 2014).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
METHYLTRANSFERASE INHIBITORS FOR TREATING CANCER
METHOD, SYSTEM AND APPARATUS FOR IMPLEMENTING HYBRID NETWORKING OF MULTIPLE CLOCK SYNCHRONIZATION TECHNOLOGIES
CONTROL DEVICE AND CONTROL METHOD FOR REMOTELY-CONTROLLED TOY AIRPLANE